Literature DB >> 12624293

Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.

Lise A Labiche1, Fahmi Al-Senani, Anne W Wojner, James C Grotta, Marc Malkoff, Andrei V Alexandrov.   

Abstract

BACKGROUND AND
PURPOSE: Early arterial recanalization can lead to dramatic recovery (DR) during intravenous tissue plasminogen activator (tPA) therapy. However, it remains unclear whether this clinical recovery is sustained 3 months after stroke.
METHODS: We studied consecutive patients treated with intravenous tPA (0.9 mg/kg within 3 hours) who had M1 or proximal M2 middle cerebral artery occlusion on pretreatment transcranial Doppler according to previously validated criteria. Patients were continuously monitored for 2 hours after tPA bolus to determine complete, partial, or no early recanalization with the Thrombolysis in Brain Ischemia (TIBI) flow grading system. A neurologist obtained the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) scores independently of transcranial Doppler results. DR was defined as a total NIHSS score of 0 to 3 points, and early recovery (ER) was defined improvement by > or =10 points at 2 hours after tPA bolus. Good long-term outcome was defined as an NIHSS score of 0 to 2 or an mRS score of 0 to 1 at 3 months.
RESULTS: Fifty-four patients with proximal middle cerebral artery occlusion had a median prebolus NIHSS score of 16 (range, 6 to 28; 90% with > or =10 points). The tPA bolus was given at 130+/-32 minutes (median, 120 minutes; 57% treated within the first 2 hours). DR+ER was observed in 50% of patients with early complete recanalization (n=18), 17% with partial recanalization (n=18), and 0% with no early recanalization (n=18) (P=0.025). Overall, DR+ER was observed in 12 patients (22%), and 9 (75%) had good outcome at 3 months in terms of NIHSS (P=0.009) and mRS (P=0.006) scores compared with non-DR and non-ER patients. If early recanalization was complete, 50% of these patients had good outcome at 3 months, and 78% with DR+ER sustained early clinical benefit. If recanalization was partial, 44% had good long-term outcome, and 66% of patients with DR+ER sustained the benefit. If no early recanalization occurred, 22% had good long-term outcome despite the lack of DR within 2 hours of tPA bolus (P=0.046). Mortality was 11%, 11%, and 39% in patients with complete, partial, and no early recanalization, respectively (P=0.025). Reasons for not sustaining DR in patients with early recanalization were subsequent symptomatic intracranial hemorrhage and recurrent ischemic stroke.
CONCLUSIONS: DR or ER after recanalization within 2 hours after tPA bolus was sustained at 3 months in most patients (75%) in our study. Complete or partial early recanalization leads to better outcome at 3 months after stroke. Fewer patients achieve good long-term outcome without early recanalization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624293     DOI: 10.1161/01.STR.0000055940.00316.6B

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Combination treatment with rt-PA is more effective than rt-PA alone in an in vitro human clot model.

Authors:  Jason M Meunier; Christy K Holland; Tyrone M Porter; Christopher J Lindsell; George J Shaw
Journal:  Curr Neurovasc Res       Date:  2011-11       Impact factor: 1.990

2.  Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome.

Authors:  Osama O Zaidat; Jose I Suarez; Jeffrey L Sunshine; Robert W Tarr; Michael J Alexander; Tony P Smith; David S Enterline; Warren R Selman; Dennis M D Landis
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 3.  Hyperacute imaging of ischemic stroke: role in therapeutic management.

Authors:  Scott L Selco; David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

Review 4.  The endovascular management of intracranial vascular disease including the MERCI device.

Authors:  Chirag D Gandhi; David M Johnson; Aman B Patel
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

Review 5.  Endovascular therapy in hyperacute ischaemic stroke: history and current status.

Authors:  Alex M Mortimer; Marcus D Bradley; Shelley A Renowden
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

Review 6.  Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease.

Authors:  Vijay K Sharma; Georgios Tsivgoulis; Annabelle Y Lao; Andrei V Alexandrov
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

7.  A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window.

Authors:  Weihua Guan; Yumei Zhao; Chao Xu
Journal:  Transl Stroke Res       Date:  2010-11-16       Impact factor: 6.829

8.  Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.

Authors:  O C Singer; J Berkefeld; M W Lorenz; J Fiehler; G W Albers; M G Lansberg; A Kastrup; A Rovira; D S Liebeskind; A Gass; C Rosso; L Derex; J S Kim; T Neumann-Haefelin
Journal:  Cerebrovasc Dis       Date:  2009-02-16       Impact factor: 2.762

9.  Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis.

Authors:  W Yoon; M S Park; K H Cho
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-27       Impact factor: 3.825

10.  Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke.

Authors:  N Janjua; A Alkawi; M F K Suri; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-16       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.